90 related articles for article (PubMed ID: 11957132)
1. The percentage of superantigen-reactive T cells in peripheral blood significantly decreases before massively increasing in patients with neonatal TSS-like exanthematous disease in the early acute phase.
Kato H; Takahashi N; Arimura Y; Imanishi K; Nishida H; Uchiyama T
J Infect Chemother; 2002 Mar; 8(1):111-4. PubMed ID: 11957132
[TBL] [Abstract][Full Text] [Related]
2. The percentage of superantigen-reactive T cells in peripheral blood significantly decreases before massively increasing in patients with neonatal TSS-like exanthematous disease in the early acute phase.
Okada T
J Infect Chemother; 2002 Mar; 8(1):118-9. PubMed ID: 11957134
[No Abstract] [Full Text] [Related]
3. Neonatal toxic shock syndrome-like exanthematous disease (NTED).
Takahashi N
Pediatr Int; 2003 Apr; 45(2):233-7. PubMed ID: 12709162
[TBL] [Abstract][Full Text] [Related]
4. Exanthematous disease induced by toxic shock syndrome toxin 1 in the early neonatal period.
Takahashi N; Nishida H; Kato H; Imanishi K; Sakata Y; Uchiyama T
Lancet; 1998 May; 351(9116):1614-9. PubMed ID: 9620715
[TBL] [Abstract][Full Text] [Related]
5. Selective excretion of anti-inflammatory cytokine interleukin-10 in a superantigen-inducing neonatal infectious disease.
Takahashi N; Hasegawa H; Komiyama M; Ohki T; Yada Y; Koike Y; Kawamata R; Honma Y; Momoi M
Cytokine; 2009 Jan; 45(1):39-43. PubMed ID: 19084429
[TBL] [Abstract][Full Text] [Related]
6. Overall picture of an emerging neonatal infectious disease induced by a superantigenic exotoxin mainly produced by methicillin-resistant Staphylococcus aureus.
Takahashi N; Imanishi K; Uchiyama T
Microbiol Immunol; 2013 Nov; 57(11):737-45. PubMed ID: 24033495
[TBL] [Abstract][Full Text] [Related]
7. A severe case of neonatal toxic shock syndrome-like exanthematous disease with superantigen-induced high T cell response.
Miki M; Uchiyama T; Kato H; Nishida H; Takahashi N
Pediatr Infect Dis J; 2006 Oct; 25(10):950-2. PubMed ID: 17006297
[TBL] [Abstract][Full Text] [Related]
8. Immunopathophysiological aspects of an emerging neonatal infectious disease induced by a bacterial superantigen.
Takahashi N; Kato H; Imanishi K; Miwa K; Yamanami S; Nishida H; Uchiyama T
J Clin Invest; 2000 Dec; 106(11):1409-15. PubMed ID: 11104794
[TBL] [Abstract][Full Text] [Related]
9. Change of specific T cells in an emerging neonatal infectious disease induced by a bacterial superantigen.
Takahashi N; Kato H; Imanishi K; Ohki T; Uehara R; Momoi MY; Nishida H; Uchiyama T
Microbiol Immunol; 2009 Sep; 53(9):524-30. PubMed ID: 19703246
[TBL] [Abstract][Full Text] [Related]
10. [A new exanthematous disease in newborn infants caused by exotoxins producing Staphylococcus aureus; exotoxins production of the isolates and serum levels of antitoxin antibody in the patients and umbilical cord blood].
Okada T; Furukawa S; Miwa K; Sakai R; Sugiyama J
Kansenshogaku Zasshi; 1999 Sep; 73(9):893-900. PubMed ID: 10535264
[TBL] [Abstract][Full Text] [Related]
11. An outbreak of neonatal toxic shock syndrome-like exanthematous disease (NTED) caused by methicillin-resistant Staphylococcus aureus (MRSA) in a neonatal intensive care unit.
Nakano M; Miyazawa H; Kawano Y; Kawagishi M; Torii K; Hasegawa T; Iinuma Y; Ohta M
Microbiol Immunol; 2002; 46(4):277-84. PubMed ID: 12061630
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis of toxic shock syndrome by two different systems; clinical criteria and monitoring of TSST-1-reactive T cells.
Matsuda Y; Kato H; Ono E; Kikuchi K; Muraoka M; Takagi K; Imanishi K; Itoh S; Itoh T; Ogawa T; Nitta K; Inokuchi S; Hibi T; Ohta H; Uchiyama T
Microbiol Immunol; 2008 Nov; 52(11):513-21. PubMed ID: 19090830
[TBL] [Abstract][Full Text] [Related]
13. Human scFvs That Counteract Bioactivities of Staphylococcus aureus TSST-1.
Rukkawattanakul T; Sookrung N; Seesuay W; Onlamoon N; Diraphat P; Chaicumpa W; Indrawattana N
Toxins (Basel); 2017 Feb; 9(2):. PubMed ID: 28218671
[TBL] [Abstract][Full Text] [Related]
14. T-cell response to superantigen restimulation during menstrual toxic shock syndrome.
Rasigade JP; Thomas D; Perpoint T; Peyramond D; Chidiac C; Etienne J; Vandenesch F; Lina G; Ferry T
FEMS Immunol Med Microbiol; 2011 Aug; 62(3):368-71. PubMed ID: 21492259
[TBL] [Abstract][Full Text] [Related]
15. A Term Infant of Neonatal Toxic Shock Syndrome-Like Exanthematous Disease Complicated with Hemophagocytic Syndrome.
Kaga A; Watanabe H; Miyabayashi H; Metoki T; Kitaoka S; Kumaki S
Tohoku J Exp Med; 2016 Oct; 240(2):167-170. PubMed ID: 27760897
[TBL] [Abstract][Full Text] [Related]
16. Mild forms of toxic shock syndrome toxin-1-mediated exanthematous disease related to Staphylococcus aureus infection.
Moriguchi N; Kano T; Yoshimatsu Y; Yanagida H
J Infect Chemother; 2016 Aug; 22(8):571-3. PubMed ID: 26923257
[TBL] [Abstract][Full Text] [Related]
17. Association of toxic shock syndrome toxin-secreting and exfoliative toxin-secreting Staphylococcus aureus with Kawasaki syndrome complicated by coronary artery disease.
Leung DY; Sullivan KE; Brown-Whitehorn TF; Fehringer AP; Allen S; Finkel TH; Washington RL; Makida R; Schlievert PM
Pediatr Res; 1997 Sep; 42(3):268-72. PubMed ID: 9284264
[TBL] [Abstract][Full Text] [Related]
18. Staphylococcal cell membrane antigen, a possible antigen in post-methicillin resistant Staphylococcus aureus (MRSA) infection nephritis and IgA nephropathy, exhibits high immunogenic activity that is enhanced by superantigen.
Shimizu Y; Sakurai H; Hirayama K; Seki M; Yoh K; Yamagata K; Koyama A
J Nephrol; 2005; 18(3):249-56. PubMed ID: 16013011
[TBL] [Abstract][Full Text] [Related]
19. Neonatal toxic shock syndrome-like exanthematous disease: A French case series.
Gerard R; Lehours P; Boralevi F; Sarlangue J
Pediatr Dermatol; 2023 Mar; 40(2):349-351. PubMed ID: 36305593
[TBL] [Abstract][Full Text] [Related]
20. Toxic shock syndrome: characterization of human immune responses to TSST-1 and evidence for sensitivity thresholds.
Kimber I; Nookala S; Davis CC; Gerberick GF; Tucker H; Foertsch LM; Dearman RJ; Parsonnet J; Goering RV; Modern P; Donnellen M; Morel J; Kotb M
Toxicol Sci; 2013 Jul; 134(1):49-63. PubMed ID: 23640863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
